Diurnal Group PLC (DNL.L): US FDA Accepts NDA Application for Alkindi | LiDCO Group (LID.L): Pre-Close Trading Update | Evgen Pharma (EVG.L): MoU with the University of Rochester
13 Feb 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
- Published:
13 Feb 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Diurnal Group PLC (DNL.L): US FDA Accepts NDA Application for Alkindi | LiDCO Group (LID.L): Pre-Close Trading Update | Evgen Pharma (EVG.L): MoU with the University of Rochester